Skip to content
Gut Podcast cover art

All Episodes

Gut Podcast — 134 episodes · page 1 of 2

#
Title
1

The risk of colorectal cancer with MASLD

2

Dysbiosis drives PSC-UC-associated colorectal cancer

3

Western diet-associated colorectal cancer

4

DPP-4 inhibitors and Parkinson’s disease

5

Defining a gut-peritoneum axis in endometriosis

6

Eosinophilic oesophagitis: the therapeutic potential of FOXM1 inhibition

7

Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts

8

Managing type 2 diabetes patients with MASLD

9

Targeting MASLD with new nanoparticles

10

Performance of the China-CLIF framework in acute-on-chronic liver failure

11

Predicting short-term liver transplant outcomes with graft microbial DNA signature

12

Screening and eradication of H pylori for gastric cancer prevention: Taipei Global Consensus II

13

Helicobacter pylori antibiotic resistance: a global challenge in search of solutions

14

Effective treatment of severe acute pancreatitis using COX-2 inhibitors

15

Protecting against Crohn's disease with dietary whey protein

16

Comparing diclofenac and indomethacin for prevention of post-ERCP pancreatitis

17

Studying oat ingestion in coeliac disease with purified oat protein

18

Predicting sensitivity to dietary emulsifiers using an in-vitro microbiota model

19

Antiviral treatment of chronic Hepatitis B

20

Single-cell spatial profiling of immunotypes in hepatocellular carcinoma

21

Understanding the gut-adipose-liver axis and its impact on insulin action

22

Linking breastfeeding and atopic dermatitis in infants

23

Improving CLDN18.2 BiTEs efficacy against pancreatic cancer

24

Gut microbiota signatures of vulnerability to food addiction in mice and humans

25

Gastric intestinal metaplasia: reviewing current guidelines

26

Exploring stem cell therapy for Hirschsprung disease

27

Protective function of sclerosing cholangitis on IBD

28

Linking high-fat diet and liver tumorigenesis

29

Hepatocellular carcinoma in patients with liver cirrhosis

30

Microbiome interventions for COPD protection

31

MASLD: a systemic metabolic disorder with cardiovascular and malignant complications

32

RE.GA.IN: the Real-world Gastritis Initiative

33

Prebiotic diet changes neural correlates of food decision-making in overweight adults

34

Lethal sepsis prevention with novel tripeptide RKH derived from Akkermansia muciniphila

35

Special Gut Podcast: Digestive health and climate change

36

Gastrointestinal origins for Parkinson’s disease

37

Consensus definition of sludge and microlithiasis as a possible cause of pancreatitis

38

Rome consensus on gut microbiota and faecal microbiota transplantation in IBD

39

The therapeutic potential of fasting

40

Helicobacter pylori promotes colorectal carcinogenesis

41

Single-cell transcriptomics sheds new light on pancreas biology and disease

42

Counteracting the harm of dietary emulsifiers with Akkermansia muciniphila

43

Antibiotic use as a risk factor for IBD

44

Predicting disease progression in bridging fibrosis and cirrhosis with liver stiffness

45

Assessing the impact of dietary fibre on bile acid transformation by gut bacteria in mice

46

Autoimmune gastritis: cancer risk in consistently tested H. pylori-negative patients

47

FMT-AID trial shows effectiveness in inducing remission of ulcerative colitis

48

Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis

49

Climate change: a survey of global gastroenterology society leadership

50

Management of Helicobacter pylori infection — the Maastricht VI/Florence Consensus Report

51

Kyoto international consensus report on the gastro-oesophageal junction

52

A faecal microbiota signature with high specificity for pancreatic cancer

53

PICaSSO Histologic Remission Index in ulcerative colitis: a novel simplified histological score

54

Next-generation sequencing of bile cell-free DNA for early detection of malignant biliary strictures

55

Endoscopic full-thickness plication for the treatment of PPI-dependent GERD

56

Dysosmobacter welbionis, a new human commensal bacterium preventing diet-induced obesity

57

Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Pg-LPS

58

Proton pump inhibitors and risk of colorectal cancer

59

Sugar-sweetened beverage intake and risk of early-onset colorectal cancer among women

60

Diet quality and risk and severity of COVID-19: a prospective cohort study

61

Helicobacter pylori resistance to antibiotics in Europe

62

Blue poo: impact of gut transit time on the gut microbiome using a novel marker

63

Long-term dietary patterns associated with inflammatory features of the gut microbiome

64

Association between Brachyspira and irritable bowel syndrome with diarrhoea

65

Effect of IBD medications on COVID-19 outcomes

66

CLARITY IBD: Anti-SARS-CoV-2 antibody and vaccination responses in patients treated with infliximab

67

Long-term instability of the intestinal microbiome and its associations

68

Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitis

69

Screening and eradication of Helicobacter pylori for gastric cancer prevention

70

European Registry on Helicobacter pylori management (Hp-EuReg)

71

Driving the efficacy of prebiotic intervention in obese patients

72

Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes

73

Global burden of oesophageal and gastric cancer by histology and subsite in 2018

74

Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease

75

Efficacy of FMT for patients with IBS in a randomised, double-blind, placebo-controlled study

76

Infants born to mothers with IBD present with altered gut microbiome

77

Mediterranean diet intervention alters the gut microbiome in older people

78

Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus

79

British Society of Gastroenterology guidance for management of IBD during the Covid-19 pandemic

80

Global patterns and trends in colorectal cancer incidence in young adults

81

Guidelines on the management of inflammatory bowel disease in adults

82

European evidence-based guidelines on pancreatic cystic neoplasms

83

Viral transfer during FMT linked to better outcomes in recurrent C. diff bacterial infections

84

Colorectal cancer: research prioritisation needed in third most lethal malignancy worldwide

85

Development of an FGF19-based chimeric molecule to promote fatty liver regeneration

86

Feeding the microbiota: transducer of nutrient signals for the host

87

Dietary emulsifiers directly alter human microbiota composition

88

Faecal microbiota transplantation in clinical practice

89

BMP-9 interferes with liver regeneration and promotes liver fibrosis

90

A systematic review of isolated colonic Crohn’s disease: the third IBD?

91

Gut microbiome and liver diseases

92

Antibiotics as deep modulators of gut microbiota: between good and evil.

93

Asia-Pacific consensus on the management of gastro-oesophageal reflux disease

94

Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma

95

Live birth and adverse birth outcomes in women with ulcerative colitis and Crohn’s disease

96

GLP-1 based therapies: clinical implications for gastroenterologists

97

Dysbiotic gut microbiota causes transmissible Crohn’s disease-like ileitis

98

Mesalazine and thymoquinone attenuate intestinal tumour development in mice

99

Effects of bowel cleansing on the intestinal microbiota

100

Development of an enhanced human gastrointestinal epithelial culture system